2Ratnapalan S, Griffiths K, Costei A M, et al. Digoxin -carvedilol interactions in children [J]. J Pediatr, 2003,142 (5) : 572 - 574. 被引量：1
3Nakamura T, Kakumoto M, Yamashita K, et al. Factors influencing the prediction of steady state concentrations of digoxin[J]. Biol Pharm Bull,2001,24:403 - 408. 被引量：1
4Kakumoto M, Takara K, Sakaeda T, et al. MDR1 - mediated interaction of digoxin with antiarrhythmic or antianginal drugs[J]. Biol Pharm Bull,2002,25:1 604- 1 607. 被引量：1
5Laer S,Scholz H, Buschmann I, et al. Digoxin intoxication during concomitant use of amiodarone [J]. Eur J Clin Pharmacol, 1998,54: 95 - 96. 被引量：1
6Boyd RA, Stern RH, Stewart BH, et al. Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal Pglycoprotein -mediated secretion [J]. J Clin Pharmacol, 2000,40:91 - 98. 被引量：1
7Wang E, Casciano CN, Clement RP, et al. HMG - CoA redactase inhibitors(statins) characterized as direct inhibitors of P- glyeoprotein[J] . Pharm Res, 2001, 18:800 - 806. 被引量：1
8Okamura N,Hirai M,Tanigawara Y,et al. Digoxin - cyclosporin A interaction:modulation of the muhidrug transporter P- glycoprotein in the kidney[J].J Pharmacol Exp Ther, 1993, 266:1 614- 1 619. 被引量：1
9Rengelshausen J, Goggelmann C , Burhenne J, et al. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin - clarithromycin interaction [J]. Br J Clin Pharmacol,2003,56(1): 32 -38. 被引量：1
10Tanaka H, Matsumoto K, Ueno K, et al. Effect of clarithromycin on steady-state digoxin concentralions[J] .Ann Pharmacother, 2003, 37(2): 178 - 181. 被引量：1
